Verano Announces Fourth Quarter and Full Year 2023 Financial Results
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the fourth quarter and full year ended December 31, 2023, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).
Fourth Quarter and Full Year 2023 Financial Highlights
For the Three Months Ended,
For the Year Ended,
($ in thousands)
December 31, 2023
September 30, 2023
December 31, 2022
December 31, 2023
December 31, 2022
Revenues, net of Discounts
$
237,189
$
240,088
$
225,927
$
938,452
$
879,412
Gross Profit
117,610
133,220
103,336
475,206
423,062
Income (Loss) from Operations
(11,143
)
40,288
(206,977
)
93,357
(161,131
)
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries
(72,579
)
(17,842
)
(216,110
)
(112,719
)
(269,164
)
Adjusted EBITDA2
73,376
89,349
78,713
304,871
323,567
Fourth Quarter 2023 Financial Highlights
Revenue of $237 million, an increase of 5% year-over-year, and decrease of 1% versus the prior quarter.
Gross profit of $118 million or 50% of revenue.
SG&A expense of $86 million or 36% of revenue.
Net loss of $(73) million or (31)% of revenue.
Adjusted EBITDA2 of $73 million or 31% of revenue.
Net cash provided by operating activities of $32 million.
Capital expenditures of $10 million.
Free cash flow1 of $23 million.
Full Year 2023 Financial Highlights
Revenue of $938 million, an increase of 7% year-over-year.
Gross profit of $475 million or 51% of revenue.
SG&A expense of $332 million or 35% of revenue.
Net loss of $(113) million or (12)% of revenue.
Adjusted EBITDA2 of $305 million or 32% of revenue.
Net cash provided by operating activities of $110 million.
Capital expenditures of $36 million.
Free cash flow1 of $73 million.
Management Commentary
“I’m incredibly proud of our performance in 2023, highlighted by key wins across all aspects of the business,” said George Archos, Verano Founder and Chief Executive Officer. “As excitement and anticipation builds in the industry, 2024 has the potential to be a game-changing year, and Verano is well positioned to continue capitalizing on growth opportunities both in the current regulatory environment and from any state or federal reform. While we’ve never been dependent on legislation to drive sustained growth, with adult use imminent in Ohio, on the horizon in Florida and Pennsylvania, and the growing anticipation of a federal rescheduling decision, there is limitless potential for Verano. I’m thankful for all that our team accomplished in 2023, and believe the sky is the limit for what we can achieve in 2024 and beyond.”
Fourth Quarter 2023 Financial Overview
Revenue for the fourth quarter 2023 was $237 million, up 5% from $226 million for the fourth quarter 2022, and down 1% from $240 million for the third quarter 2023. The increase in revenue for the fourth quarter 2023 compared to the fourth quarter 2022 was driven primarily by strength from wholesale adult use sales in New Jersey, in addition to growth in Maryland and Florida retail.
Gross profit for the fourth quarter 2023 was $118 million or 50% of revenue, up from $103 million or 46% of revenue for the fourth quarter 2022, and down from $133 million or 55% of revenue for the third quarter 2023. The increase in gross profit for the fourth quarter 2023 compared to the fourth quarter 2022 was driven primarily by increased vertical mix and revenue growth.
SG&A expense for the fourth quarter 2023 was $86 million or 36% of revenue, up from $81 million or 36% of revenue for the fourth quarter 2022, and flat with $86 million or 36% of revenue for the third quarter 2023.
Net loss for the fourth quarter 2023 was $(73) million, or (31)% of revenue, versus a loss of $(216) million in the fourth quarter 2022, and $(18) million for the third quarter 2023. The decrease in net loss for the fourth quarter 2023 compared to the fourth quarter 2022 was due to a $229 million impairment charge in the prior year period. Excluding the impacts from impairments, net loss for the fourth quarter 2023 was primarily driven by the increase in provision for income taxes as the Company increased income from operations versus the fourth quarter 2022.
Adjusted EBITDA2 for the fourth quarter 2023 was $73 million or 31% of revenue.
Net cash provided by operating activities for the fourth quarter 2023 was $32 million, up from $29 million for the fourth quarter 2022.
Capital expenditures for the fourth quarter 2023 were $10 million, up from $9 million for the fourth quarter 2022.
Free cash flow1 for the fourth quarter 2023 was $23 million, up from $20 million for the fourth quarter 2022.
Full Year 2023 Financial Overview
Revenue for full year 2023 was $938 million, up 7% from $879 million for full year 2022. The increase in revenue for full year 2023 compared to full year 2022 was driven by a full year’s adult use contribution from New Jersey in addition to adult use launches in Connecticut and Maryland.
Gross profit for full year 2023 was $475 million or 51% of revenue, up from $423 million or 48% of revenue for full year 2022. The increase in gross profit for full year 2023 compared to full year 2022 was driven primarily by increased vertical mix and revenue growth.
SG&A expense for full year 2023 was $332 million or 35% of revenue, down from $357 million or 41% of revenue for full year 2022. The decrease in SG&A expense was driven primarily by a decrease in stock based compensation.
Net loss for full year 2023 was $(113) million, or (12)% of revenue, down from $(269) million for full year 2022. The decrease in net loss for full year 2023 compared to the full year 2022 was due to a $229 million impairment charge in the prior year period. Excluding the impacts from impairments, net loss for the full year 2023 was primarily driven by the increase in provision for income taxes as the Company increased income from operations versus the full year 2022.
Adjusted EBITDA2 for full year 2023 was $305 million or 32% of revenue.
Net cash provided by operating activities for full year 2023 was $110 million, up from $94 million for full year 2022.
Capital expenditures for full year 2023 were $36 million, down from $119 million for full year 2022.
Free cash flow1 for full year 2023 was $73 million, up from $(25) million for full year 2022.
2024 Guidance
The Company issued first quarter 2024 revenue guidance of a 5-7% decline versus the prior year period as the growing dispensary count in New Jersey continues to normalize.
Fourth Quarter 2023 Operational Highlights
Expanded the Company’s retail footprint across key markets by opening the following new dispensaries:
MÜV locations in Apopka, Satellite Beach and North Miami-Biscayne, Florida;
and Zen Leaf Newington, a social equity joint venture dispensary, raising the Company’s Connecticut retail footprint to four locations statewide.
Commenced trading on Cboe Canada, elevating the Company’s capital markets strategy and presence on a senior exchange with a global platform that spans 26 markets.
Introduced Savvy Threads, a non-plant-touching e-commerce extension of the Company’s Savvy brand featuring limited-edition, artist-driven streetwear available for sale and delivery to all 50 states.
Announced the Company’s participation in a coalition of industry stakeholders as a plaintiff challenging the legality of the federal government’s intervention in legal intrastate cannabis commerce under the Commerce Clause and Controlled Substances Act.
Launched reimagined (the) Essence brand combining bespoke graphic art and terpene-rich full-spectrum products, including the new (the) Essence Nectar line, across core markets.
Subsequent Operational Highlights
Expanded the Company’s retail footprint across key markets by opening the following new dispensaries:
MÜV Yulee in Northeast Florida, raising the Company’s current statewide retail footprint to 74 dispensaries;
and in Pennsylvania, opened the Company’s largest nationwide dispensary, Zen Leaf Abington, and Zen Leaf Norristown – both situated in prime Philadelphia area locations – elevating Verano’s statewide footprint to 18 affiliated dispensaries.
Current operations span 13 states, comprised of 138 dispensaries and 14 production facilities with more than one million square feet of cultivation capacity.
Balance Sheet and Liquidity
As of December 31, 2023, the Company’s current assets were $394 million, including cash and cash equivalents of $175 million. The Company had a working capital deficit of $(18) million and total debt, net of issuance costs, of $446 million.
The Company’s total Class A subordinate voting shares outstanding was 344,074,096 as of December 31, 2023.
Conference Call and Webcast
A conference call and webcast with analysts and investors is scheduled for February 29, 2024 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results and answer investor and participant questions.
Investors and participants can register in advance for the call by visiting: https://conferencingportals.com/event/sxTSCKLn
After registering, instructions will be shared on how to join the call for those who wish to dial in.
On February 29, 2024, the live webcast can be accessed via the following link: https://events.q4inc.com/attendee/601934273
The live and archived webcast will be available on the Events and Presentations page of the Company’s investor relations website at investors.verano.com.
_________________________
1 Free cash flow is a non-U.S. GAAP financial measure. It is derived from U.S. GAAP net cash provided by operating activities, which is also its most directly comparable U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The reconciliation of free cash flow to U.S. GAAP net cash provided by operating activities is set forth below in the tables included in this news release.
2 Adjusted EBITDA is a non-U.S. GAAP financial measure. It is derived from EBITDA, another non-U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The most directly comparable U.S. GAAP financial measure to adjusted EBITDA is net income (loss). The reconciliation of adjusted EBITDA to U.S. GAAP net income (loss) is set forth below in the tables included in this news release.
Non-U.S. GAAP Financial Measures
Verano uses non-U.S. GAAP financial information to evaluate the performance of the Company. The terms “EBIT,” “EBITDA,” “adjusted EBITDA,” and “free cash flow” do not have any standardized meaning prescribed within U.S. GAAP and therefore may not be comparable to similar measures presented by other companies. Accordingly, this non-U.S. GAAP financial information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with U.S. GAAP.
The Company calculates EBIT as net income (loss) before interest expense and income tax expense; EBITDA as net income (loss) before interest expense, income tax expense, depreciation, and amortization; adjusted EBITDA as net income (loss) plus net interest expense, income tax expense, depreciation and amortization and also excludes certain one-time extraordinary items; and free cash flow as net cash provided by operating activities less capital expenditures. The calculations of the non-U.S. GAAP financial measures used in this news release and the reconciliations to the most comparable U.S. GAAP financial numbers are included in the tables below.
Management believes that this non-U.S. GAAP financial information is useful as a supplement to comparable U.S. GAAP financial information because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP information to supplement their GAAP results. Management reviews these non-U.S. GAAP financial measures on a regular basis and uses them, together with financial measures included in the Company’s financial statements, to evaluate and manage the performance of the Company’s operations. These measures should be evaluated only in conjunction with the comparable U.S. GAAP financial numbers reported by the Company.
About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano offers a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1,000,000 square feet of cultivation capacity. Learn more at www.verano.com.
Contacts:
Investors
Verano
Julianna Paterra, CFA
VP, Investor Relations
julianna.paterra@verano.com
Media
Verano
Steve Mazeika
VP, Communications
steve.mazeika@verano.com
312-348-4430
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2023 to be filed subsequent to a date hereof with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
Financial Information Tables
The following tables include select financial results and the reconciliations of the non-U.S. GAAP financial measures to the respective most directly comparable U.S. GAAP financial measures for the presented periods.
VERANO HOLDINGS CORP.
Highlights from Unaudited Consolidated Statements of Operations
($ in Thousands)
For the Three Months Ended,
For the Year Ended,
December 31, 2023
September 30, 2023
December 31, 2022
December 31, 2023
December 31, 2022
Revenues, net of Discounts
$
237,189
$
240,088
$
225,927
$
938,452
$
879,412
Cost of Goods Sold, net
119,579
106,868
122,591
463,246
456,350
Gross Profit
117,610
133,220
103,336
475,206
423,062
Gross Profit %
50
%
55
%
46
%
51
%
48
%
Operating Expenses
Selling, General and Administrative
85,709
86,316
81,038
331,928
356,569
Loss on Impairment of Investment in Associates
—
6,571
—
6,571
—
Loss on Impairment of Intangibles – Goodwill
37,931
—
113,031
37,931
113,031
Loss on Impairment of Intangibles – License
5,113
—
116,151
5,113
116,151
Total Operating Expenses
128,753
92,887
310,220
381,543
585,751
Income (Loss) from Investments in Associates
—
(45
)
(93
)
(306
)
1,558
Income (Loss) from Operations
(11,143
)
40,288
(206,977
)
93,357
(161,131
)
Other Income (Expense), net:
Loss on Disposal of Property, Plant and Equipment
(568
)
(234
)
(408
)
(1,123
)
(157
)
Gain on Deconsolidation
—
—
—
—
9,560
Gain on Previously Held Equity Interest
—
—
—
—
14,103
Loss on Debt Extinguishment
—
—
(7,987
)
(663
)
(7,987
)
Interest Expense, net
(14,708
)
(15,166
)
(15,349
)
(59,793
)
(49,431
)
Other Income, net
2,057
2,145
14,083
4,594
31,640
Total Other Income (Expense), Net
(13,219
)
(13,255
)
(9,661
)
(56,985
)
(2,272
)
Income (Loss) Before Provision for Income Taxes and Non-Controlling Interest
(24,362
)
27,033
(216,638
)
36,372
(163,403
)
Provision for Income Tax (Expense) Benefit
(48,295
)
(44,797
)
528
(149,091
)
(105,470
)
Net Income (Loss) Attributable To Non-Controlling Interest
(78
)
78
—
—
291
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries
(72,579
)
(17,842
)
(216,110
)
(112,719
)
(269,164
)
VERANO HOLDINGS CORP.
Highlights from Unaudited Consolidated Balance Sheets
($ in Thousands)
December 31,
December 31,
2023
2022
Cash and Cash Equivalents
$
174,760
$
84,851
Other Current Assets
219,436
233,424
Property and Equipment, Net
509,877
525,905
Intangible Assets, Net
1,086,146
1,180,766
Goodwill
231,291
269,088
Other Long-Term Assets
105,808
102,021
Total Assets
$
2,327,318
$
2,396,055
Total Current Liabilities
$
412,188
$
386,645
Total Long-Term Liabilities
670,421
667,860
Total Shareholders’ Equity
1,244,709
1,341,550
Non-Controlling Interest
—
—
Total Liabilities and Shareholders’ Equity
$
2,327,318
$
2,396,055
VERANO HOLDINGS CORP.
Segmented Revenue By State (Unaudited)
For the Three Months Ended,
For the Year Ended,
Net Retail Sales by State
December 31, 2023
December 31, 2023
($ in thousands)
Florida
$
59,695
$
221,957
Illinois
29,299
123,040
New Jersey
26,337
126,876
Arizona
15,626
67,061
Pennsylvania
12,587
55,010
Maryland
10,875
28,594
Connecticut
8,862
29,673
Nevada
7,097
29,158
Ohio
5,868
25,152
Massachusetts
2,984
12,628
West Virginia
1,625
5,777
Other
4,264
16,500
Total Net Retail Sales
$
185,119
$
741,426
For the Three Months Ended,
For the Year Ended,
Wholesale Sales by State
December 31, 2023
December 31, 2023
Gross
Net1
Gross
Net1
($ in thousands)
New Jersey
$
24,049
$
15,511
$
99,928
$
51,291
Illinois
19,227
11,027
79,204
45,858
Connecticut
14,204
10,342
54,584
42,011
Maryland
8,444
5,384
28,273
19,357
Pennsylvania
7,476
3,781
29,168
15,903
Arizona
7,084
2,575
25,989
9,888
Nevada
2,924
845
10,359
2,963
Ohio
1,857
914
7,816
3,693
Massachusetts
1,640
809
6,967
3,249
West Virginia
1,665
882
5,528
2,793
Other
—
—
20
20
Total Wholesale Sales
$
88,570
$
52,070
$
347,836
$
197,026
1Net of intercompany eliminations
VERANO HOLDINGS CORP.
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow (Non-U.S. GAAP)
For the Three Months Ended,
For the Year Ended,
December 31, 2023
December 31, 2022
December 31, 2023
December 31, 2022
($ in thousands)
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
Net Cash Provided by Operating Activities
$
32,349
$
29,036
$
109,710
$
94,347
Purchase of property, plant, and equipment
(9,827
)
(9,454
)
(36,330
)
(119,174
)
Free Cash Flow
$
22,522
$
19,582
$
73,380
$
(24,827
)
VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBITDA (Non-U.S. GAAP)
For the Three Months Ended,
For the Year Ended,
December 31, 2023
September 30, 2023
December 31, 2022
December 31, 2023
December 31, 2022
($ in thousands)
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries
$
(72,579
)
$
(17,842
)
$
(216,110
)
$
(112,719
)
$
(269,164
)
Interest Expense, net
14,708
15,166
15,349
59,793
49,431
Income Tax Expense (Benefit)
48,295
44,797
(528
)
149,091
105,470
Depreciation and Amortization – COGS
18,417
18,384
18,580
73,851
78,120
Depreciation and Amortization – SG&A
17,157
16,882
16,578
67,282
63,267
Earnings (Loss) Before Interest, Taxes, Depreciation and Amortization (EBITDA)
$
25,998
$
77,387
$
(166,131
)
$
237,298
$
27,124
VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBIT (Non-U.S. GAAP) and Adjusted EBITDA (Non-U.S. GAAP)
For the Three Months Ended,
For the Year Ended,
December 31, 2023
September 30, 2023
December 31, 2022
December 31, 2023
December 31, 2022
($ in thousands)
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries
$
(72,579
)
$
(17,842
)
$
(216,110
)
$
(112,719
)
$
(269,164
)
Interest Expense, Net
14,708
15,166
15,349
59,793
49,431
Income Tax Expense
48,295
44,797
(528
)
149,091
105,470
Earnings Before Interest, Taxes (EBIT)
$
(9,576
)
$
42,121
$
(201,289
)
$
96,165
$
(114,263
)
COGS Add-backs:
Depreciation and Amortization – COGS
18,417
18,384
18,580
73,851
78,120
Acquisition, Transaction and Other Non-operating Costs
—
—
695
—
20,804
Employee Stock Compensation
970
625
2,231
2,669
8,003
SG&A Add-backs:
Depreciation and Amortization – SG&A
17,157
16,882
16,578
67,282
63,267
Acquisition, Transaction and Other Non-operating Costs
595
617
1,043
2,177
22,224
Employee Stock Compensation
3,281
4,062
2,599
10,561
31,051
Impairment – Goodwill & License
43,044
—
229,182
43,044
229,182
Acquisition Adjustments and Other Income (Expense), net
(512
)
6,658
9,094
9,122
(14,821
)
Adjusted EBITDA
$
73,376
$
89,349
$
78,713
$
304,871
$
323,567
Net Loss Margin
(31) %
(7) %
(96) %
(12) %
(31) %
Adjusted EBITDA Margin
31
%
37
%
35
%
32
%
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
